These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32162652)

  • 21. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.
    Roberts SK; Gazzola A; Lubel J; Gow P; Bell S; Nicoll A; Dev A; Fink MA; Sood S; Knight V; Hong T; Paul E; Mishra G; Majeed A; Kemp W;
    Scand J Gastroenterol; 2018; 53(10-11):1368-1375. PubMed ID: 30394145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation.
    Invernizzi F; Iavarone M; Zavaglia C; Mazza S; Maggi U; Cesarini L; Antonelli B; Airoldi A; Manini MA; Sangiovanni A; Rossi G; Donato MF; Saverio Belli L; Lampertico P
    Transplantation; 2020 Mar; 104(3):568-574. PubMed ID: 31517781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Yuan P; Chen P; Qian Y
    Can J Gastroenterol Hepatol; 2016; 2016():5234969. PubMed ID: 27446846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
    Liu D; Song T
    Biosci Trends; 2021 Jul; 15(3):142-147. PubMed ID: 33716267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
    Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
    World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.
    Lee O; Rhu J; Choi GS; Kim JM; Kim K; Joh JW
    Ann Transplant; 2022 Apr; 27():e935604. PubMed ID: 35379768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
    Cabibbo G; Petta S; Barbàra M; Missale G; Virdone R; Caturelli E; Piscaglia F; Morisco F; Colecchia A; Farinati F; Giannini E; Trevisani F; Craxì A; Colombo M; Cammà C;
    Liver Int; 2017 Aug; 37(8):1157-1166. PubMed ID: 28061016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
    Lan T; Chang L; Mn R; Wu L; Yuan YF
    Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling.
    Kim DG; Yim SH; Min EK; Choi MC; Kim MS; Joo DJ; Lee JG
    Liver Int; 2023 Sep; 43(9):2017-2025. PubMed ID: 37365992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
    Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
    BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
    Zhao H; Zheng M; Wang K; Wang L; He H; Wang M; Shi Y; Huang S; Ji F; Li X; Zhu H; Wang L; Zhang X; Shi X; Zhao S; Fu B; Wu T
    J Cancer Res Ther; 2018; 14(4):807-814. PubMed ID: 29970657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
    Yang B; Zheng B; Yang M; Zeng Z; Yang F; Pu J; Li C; Liao Z
    Hepatol Int; 2018 Sep; 12(5):417-428. PubMed ID: 30073454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.